487-06-9

• 常用中文名：柠檬油素
• 常用英文名：Citropten
• CAS号：487-06-9
• 分子式：C₁₁H₁₀O₄
• 分子量：206.195
• 相关类别： 医药中间体 杂环化合物 吡喃类化合物
• 发布时间：2018-06-22 11:04:08
• 更新时间：2024-01-02 10:29:36
• Citropten (5,7-Dimethoxycoumarin) 是从佛手柑油中分离出的一种香豆素。Citropten (5,7-Dimethoxycoumarin) 对 A2058 人黑色素瘤细胞株具有抗增殖活性。

名称

• 中文名: 5,7-二甲氧基香豆素
• 英文名: 5,7-Dimethoxycoumarin
• 中文别名: 柠美内酯; 白檬素; 5,7-二甲氧香豆素
• 英文别名: 5,7-Dimethoxy-2H-1-benzopyran-2-one; MFCD00006870; 5,7-dimethoxy-coumarin; EINECS 207-646-4; Limettin; Citropten; 5,7-Dimethoxy-2H-chromen-2-one; 2H-1-Benzopyran-2-one, 5,7-dimethoxy-; 5,7-dimethoxychromen-2-one; 5,7-Dimethoxycoumarin; 5,7-Dimethoxy-chromen-2-one

物化性质

• 密度: 1.2±0.1 g/cm3
• 沸点: 388.1±42.0 °C at 760 mmHg
• 熔点: 146-149 °C(lit.)
• 分子式: C₁₁H₁₀O₄
• 分子量: 206.195
• 闪点: 176.3±27.9 °C
• 精确质量: 206.057907
• PSA: 48.67000
• LogP: 2.06
• 外观性状: 黄色至黄褐色的或棕色粉末或结晶粉末
• 蒸汽压: 0.0±0.9 mmHg at 25°C
• 折射率: 1.557
• 储存条件:

  2-8°C

  密封保存，放置在通风，干燥的环境中 暂无

• 稳定性:

  按规格使用和贮存，不会发生分解，避免与氧化物接触

• 分子结构:

  1、 摩尔折射率：53.12

  2、 摩尔体积（m³/mol）：165.1

  3、 等张比容（90.2K）：21422.8

  4、 表面张力（3.0 dyne/cm）：43.0

  5、 极化率（0.5 10 ^-24cm ³）：21.05

• 计算化学:

  1.疏水参数计算参考值（XlogP）:1.9

  2.氢键供体数量:0

  3.氢键受体数量:4

  4.可旋转化学键数量:2

  5.互变异构体数量:无

  6.拓扑分子极性表面积44.8

  7.重原子数量:15

  8.表面电荷:0

  9.复杂度:274

  10.同位素原子数量:0

  11.确定原子立构中心数量:0

  12.不确定原子立构中心数量:0

  13.确定化学键立构中心数量:0

  14.不确定化学键立构中心数量:0

  15.共价键单元数量:1

• 更多:

  1. 性状：未确定

  2. 密度（g/ m³,25/4℃）：未确定

  3. 相对蒸汽密度（g/cm³,空气=1）：未确定

  4. 熔点（ºC）：146-149

  5. 沸点（ºC,常压）：未确定

  6. 沸点（ºC,5.2kPa）：未确定

  7. 折射率：未确定

  8. 闪点（ºF）：未确定

  9. 比旋光度（º）：未确定

  10. 自燃点或引燃温度（ºC）：未确定

  11. 蒸气压（kPa,25ºC）：未确定

  12. 饱和蒸气压（kPa,60ºC）：未确定

  13. 燃烧热（KJ/mol）：未确定

  14. 临界温度（ºC）：未确定

  15. 临界压力（KPa）：未确定

  16. 油水（辛醇/水）分配系数的对数值：未确定

  17. 爆炸上限（%,V/V）：未确定

  18. 爆炸下限（%,V/V）：未确定

  19. 溶解性：未确定

生物活性

• 描述: Citropten (5,7-Dimethoxycoumarin) 是从佛手柑油中分离出的一种香豆素。Citropten (5,7-Dimethoxycoumarin) 对 A2058 人黑色素瘤细胞株具有抗增殖活性。
• 相关类别:
  研究领域 >> 癌症
  信号通路 >> 其他 >> 其他
• 参考文献:

  [1]. Makki S, et al. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans. J Chromatogr. 1991 Feb 15;563(2):407-13.

  [2]. Wolny D, et al. Antiproliferative effect of valproic acid and 5,7-dimethoxycoumarin against A2058 human melanoma cells. Acta Pol Pharm. 2014 Nov-Dec;71(6):1056-9.

MSDS

SECTION 1: Identification of the substance/mixture and of the company/undertaking Product identifiers Product name: 5,7-Dimethoxycoumarin REACH No.: A registration number is not available for this substance as the substance or its uses are exempted from registration, the annual tonnage does not require a registration or the registration is envisaged for a later registration deadline. CAS-No.: 487-06-9 Relevant identified uses of the substance or mixture and uses advised against Identified uses: Laboratory chemicals, Manufacture of substances SECTION 2: Hazards identification Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Skin sensitisation (Category 1), H317 For the full text of the H-Statements mentioned in this Section, see Section 16. Classification according to EU Directives 67/548/EEC or 1999/45/EC Xi IrritantR43 For the full text of the R-phrases mentioned in this Section, see Section 16. Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal wordWarning Hazard statement(s) H317May cause an allergic skin reaction. Precautionary statement(s) P280Wear protective gloves. Supplemental Hazardnone Statements Other hazards - none SECTION 3: Composition/information on ingredients Substances Synonyms: Citropten Limettin Formula: C11H10O4 Molecular Weight: 206,19 g/mol CAS-No.: 487-06-9 EC-No.: 207-646-4 Hazardous ingredients according to Regulation (EC) No 1272/2008 ComponentClassificationConcentration 5,7-Dimethoxy-2-benzopyrone CAS-No.487-06-9Skin Sens. 1; H317<= 100 % EC-No.207-646-4 Hazardous ingredients according to Directive 1999/45/EC ComponentClassificationConcentration 5,7-Dimethoxy-2-benzopyrone CAS-No.487-06-9Xi, R43<= 100 % EC-No.207-646-4 For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16 SECTION 4: First aid measures Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Flush eyes with water as a precaution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 Indication of any immediate medical attention and special treatment needed no data available SECTION 5: Firefighting measures Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards arising from the substance or mixture Carbon oxides Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. Further information no data available SECTION 6: Accidental release measures Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Avoid breathing dust. For personal protection see section 8. Environmental precautions Do not let product enter drains. Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. Reference to other sections For disposal see section 13. SECTION 7: Handling and storage Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2. Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Specific end use(s) A part from the uses mentioned in section 1.2 no other specific uses are stipulated SECTION 8: Exposure controls/personal protection Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Do not let product enter drains. SECTION 9: Physical and chemical properties Information on basic physical and chemical properties a) AppearanceForm: crystalline Colour: white b) Odourno data available c) Odour Thresholdno data available d) pHno data available e) Melting point/freezingMelting point/range: 146 - 149 °C - lit. point f) Initial boiling point and no data available boiling range g) Flash pointno data available h) Evapouration rateno data available i) Flammability (solid, gas) no data available j) Upper/lowerno data available flammability or explosive limits k) Vapour pressureno data available l) Vapour densityno data available m) Relative densityno data available n) Water solubilityno data available o) Partition coefficient: n- no data available octanol/water p) Auto-ignitionno data available temperature q) Decompositionno data available temperature r) Viscosityno data available s) Explosive propertiesno data available t) Oxidizing propertiesno data available Other safety information no data available SECTION 10: Stability and reactivity Reactivity no data available Chemical stability Stable under recommended storage conditions. Possibility of hazardous reactions no data available Conditions to avoid no data available Incompatible materials Strong oxidizing agents Hazardous decomposition products Other decomposition products - no data available In the event of fire: see section 5 SECTION 11: Toxicological information Information on toxicological effects Acute toxicity no data available Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitisation Germ cell mutagenicity Human lymphocyte Sister chromatid exchange Carcinogenicity IARC:No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Reproductive toxicity no data available Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Additional Information RTECS: Not available photosensitivity, To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated. SECTION 12: Ecological information Toxicity no data available Persistence and degradability no data available Bioaccumulative potential no data available Mobility in soil no data available Results of PBT and vPvB assessment PBT/vPvB assessment not available as chemical safety assessment not required/not conducted Other adverse effects no data available SECTION 13: Disposal considerations Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging Dispose of as unused product. SECTION 14: Transport information UN number ADR/RID: -IMDG: -IATA: - UN proper shipping name ADR/RID: Not dangerous goods IMDG: Not dangerous goods IATA:Not dangerous goods Transport hazard class(es) ADR/RID: -IMDG: -IATA: - Packaging group ADR/RID: -IMDG: -IATA: - Environmental hazards ADR/RID: noIMDG Marine pollutant: noIATA: no Special precautions for user no data available SECTION 15 - REGULATORY INFORMATION N/A SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

毒理学数据: 致突变数据：姐妹染色单体exchangeTEST系统：人类淋巴细胞：100 umol/L 生态学数据: 该物质对环境可能有危害，对水体应给予特别注意。 CHEMICAL IDENTIFICATION RTECS NUMBER : GN6530000 CHEMICAL NAME : Coumarin, 5,7-dimethoxy- CAS REGISTRY NUMBER : 487-06-9 BEILSTEIN REFERENCE NO. : 0187066 LAST UPDATED : 199612 DATA ITEMS CITED : 1 MOLECULAR FORMULA : C11-H10-O4 MOLECULAR WEIGHT : 206.21 HEALTH HAZARD DATA ACUTE TOXICITY DATA MUTATION DATA TYPE OF TEST : Sister chromatid exchange TEST SYSTEM : Human Lymphocyte DOSE/DURATION : 100 umol/L REFERENCE : PLMEAA Planta Medica. (Georg Thieme Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1953- Volume(issue)/page/year: 42,333,1981

安全

• 符号: GHS07
• 信号词: Warning
• 危害声明: H317
• 警示性声明: P280
• 个人防护装备: Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
• 危害码 (欧洲): Xi
• 风险声明 (欧洲): 43
• 安全声明 (欧洲): 36/37
• 危险品运输编码: NONH for all modes of transport
• WGK德国: 3
• RTECS号: GN6530000

上下游产品

上游产品  10
500-99-2 471-25-0 2732-18-5 74-88-4
708-76-9 105-58-8 15568-85-1 623-47-2
121449-70-5 82235-61-8
下游产品  5
486-28-2 108-73-6 64-19-7 88140-30-1
61899-44-3